Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q53H76
UPID:
PLA1A_HUMAN
Alternative names:
Phosphatidylserine-specific phospholipase A1
Alternative UPACC:
Q53H76; B2R8V2; B4DXA2; O95991; Q86WX6; Q9UPD2
Background:
Phospholipase A1 member A, also known as Phosphatidylserine-specific phospholipase A1, plays a crucial role in the hydrolysis of the ester bond of the acyl group at the sn-1 position of phosphatidylserines. This activity is pivotal in the pathway of phosphatidylserines acyl chain remodeling. The enzyme specifically targets phosphatidylserines exposed on the outer leaflet of the plasma membrane of apoptotic cells, producing 2-acyl-1-lysophosphatidylserines, which subsequently enhance mast cell activation and histamine production.
Therapeutic significance:
Understanding the role of Phospholipase A1 member A could open doors to potential therapeutic strategies, especially in conditions where the regulation of apoptotic cell clearance and mast cell activation is crucial.